KRAS and non-small cell lung carcinoma: Recently, higher levels of DNA pol β were associated with DDP resistance, and the in vitro inhibition of DNA pol β with pamoic acid restored DDP sensitivity in KRAS (G12C) over-expressing non-small cell lung cancer (NSCLC) [40].